Urology Medical Lasers Market Seen Reaching $1.41 Billion by 2030

The global urology medical lasers market is projected to rise from $1.06 billion in 2025 to $1.41 billion by 2030 as demand grows for minimally invasive procedures in urology. North America led the market in 2025, while Asia-Pacific is expanding fastest on healthcare investment and a larger patient base.

Why it matters: - The urology medical lasers market is expanding because hospitals and outpatient centers are adopting less invasive treatments for prostate, kidney, bladder and urinary tract procedures. - The market’s growth reflects rising demand for precise tissue removal, shorter recovery times and fewer complications in urologic care. - The forecast points to a larger commercial opportunity for laser system makers as the global population ages and urological disease rates climb.

What happened: - The Business Research Company released its Urology Medical Lasers Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the market will grow from $1.06 billion in 2025 to $1.12 billion in 2026. - The report projects the market will reach $1.41 billion by 2030. - The forecast implies a 6.0% CAGR from 2025 to 2026 and a 5.8% CAGR through 2030. - North America was the largest regional market in 2025. - Asia-Pacific was the second-largest market and is growing quickly.

The details: - Urology medical lasers are used for minimally invasive surgical and therapeutic procedures in the urinary tract, bladder, kidneys, prostate and related organs. - The devices use concentrated light beams to cut, vaporize or fragment tissue. - The technology is designed to reduce bleeding and damage to surrounding healthy tissue. - The report links past growth to rising urological disorders, more urology departments in hospitals, wider use of laser-based treatments, better surgical laser availability and improved patient outcomes. - Future growth is expected to be supported by an aging male population, higher demand for benign prostatic hyperplasia and urolithiasis treatments, more ambulatory surgical procedures and continued investment in advanced laser technologies. - Emerging trends include high-power laser platforms, more minimally invasive urology procedures, multi-wavelength laser systems, outpatient laser treatments and a stronger focus on precision tissue ablation. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The market’s growth is tied less to discretionary spending and more to structural demand from aging patients and common chronic urologic conditions. - The shift toward outpatient and ambulatory procedures suggests laser systems are becoming part of a broader cost- and efficiency-driven care model. - The focus on multi-wavelength and high-power platforms points to competition around performance, precision and procedure versatility rather than basic device availability. - The American Cancer Society projected about 81,610 new kidney cancer cases and 14,390 deaths in the U.S. in January 2024, underscoring the broader burden of urologic disease.

What's next: - Growth should continue as healthcare systems expand minimally invasive urology capabilities and invest in newer laser platforms. - Market competition is likely to center on system precision, outpatient suitability and treatment efficiency. - Regional momentum in Asia-Pacific could narrow the gap with North America if healthcare investment and patient demand keep rising.

The bottom line: - Urology medical lasers are moving from a niche surgical tool to a broader growth market, with demand anchored by aging populations and the shift to minimally invasive care.